Medlive Technology Co., Ltd.
Symboli: 2192.HK
HKSE
8.66
HKDMarkkinahinta tänään
23.2180
P/E-suhde
0.2136
PEG-suhde
6.30B
MRK Cap
- 0.02%
DIV Tuotto
Medlive Technology Co., Ltd. (2192-HK) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 17632.85 | 4400.9 | 4216.9 | 3908.7 | ||||||
balance-sheet.row.short-term-investments | 127.15 | 42.6 | 29.6 | 29.6 | ||||||
balance-sheet.row.net-receivables | 581.29 | 155.9 | 124.2 | 95.9 | ||||||
balance-sheet.row.inventory | 0.62 | 0.1 | 0.2 | 0.1 | ||||||
balance-sheet.row.other-current-assets | 229.63 | 58.3 | 35.4 | 33 | ||||||
balance-sheet.row.total-current-assets | 18279.8 | 4572.6 | 4351.7 | 4013 | ||||||
balance-sheet.row.property-plant-equipment-net | 45.37 | 11.1 | 14.6 | 16.9 | ||||||
balance-sheet.row.goodwill | 726.41 | 192.5 | 111.5 | 69.7 | ||||||
balance-sheet.row.intangible-assets | 152.99 | 66.7 | 24.3 | 9.3 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 879.4 | 259.3 | 135.9 | 79 | ||||||
balance-sheet.row.long-term-investments | 233.75 | 42.4 | 63.2 | -29.3 | ||||||
balance-sheet.row.tax-assets | 17.98 | 8.5 | 8.3 | 6.3 | ||||||
balance-sheet.row.other-non-current-assets | 96.83 | 0 | 29.6 | 29.6 | ||||||
balance-sheet.row.total-non-current-assets | 1273.32 | 321.2 | 251.5 | 102.6 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.account-payables | 36.9 | 14.8 | 2.7 | 6.2 | ||||||
balance-sheet.row.short-term-debt | 8.87 | 4.5 | 5.1 | 4.2 | ||||||
balance-sheet.row.tax-payables | 46.5 | 25.7 | 35.2 | 31.6 | ||||||
balance-sheet.row.long-term-debt-total | 15.72 | 3.6 | 6.1 | 9 | ||||||
Deferred Revenue Non Current | -7.54 | -7.5 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.66 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 770 | 175 | 124.9 | 102.8 | ||||||
balance-sheet.row.total-non-current-liabilities | 168.82 | 58.8 | 38.6 | 30.2 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 33.45 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.total-liab | 980.04 | 248.6 | 171.3 | 143.4 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 39 | ||||||
balance-sheet.row.common-stock | 0.18 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 1070.8 | 284.9 | 175.3 | 75.6 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 5901.59 | 4597.3 | 308.1 | -39 | ||||||
balance-sheet.row.other-total-stockholders-equity | 11434.72 | -284.9 | 3917.6 | 3873 | ||||||
balance-sheet.row.total-stockholders-equity | 18407.29 | 4597.4 | 4401 | 3948.7 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.minority-interest | 165.8 | 47.8 | 30.9 | 23.5 | ||||||
balance-sheet.row.total-equity | 18573.09 | 4645.2 | 4431.9 | 3972.2 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 19553.12 | - | - | - | ||||||
Total Investments | 318.26 | 42.4 | 92.8 | 0.3 | ||||||
balance-sheet.row.total-debt | 24.58 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.net-debt | -17438.47 | -4350.1 | -4176 | -3865.9 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 242.3 | 242.3 | 135 | 69.9 | ||||||
cash-flows.row.depreciation-and-amortization | 9.21 | 0 | 9 | 6.1 | ||||||
cash-flows.row.deferred-income-tax | -19.3 | 0 | 0 | -13.7 | ||||||
cash-flows.row.stock-based-compensation | 10.41 | 10.4 | 17.2 | 14.3 | ||||||
cash-flows.row.change-in-working-capital | 15.77 | 0 | -9.6 | -27.9 | ||||||
cash-flows.row.account-receivables | -16.32 | 0 | -25.1 | -31.7 | ||||||
cash-flows.row.inventory | 0.1 | 0 | -0.1 | -0.1 | ||||||
cash-flows.row.account-payables | 0.17 | 0 | 25.1 | 31.7 | ||||||
cash-flows.row.other-working-capital | 31.98 | 0 | -9.5 | -27.8 | ||||||
cash-flows.row.other-non-cash-items | -175.83 | -252.7 | -74.5 | -4.4 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 101.87 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.acquisitions-net | -56.39 | 0 | -42.6 | -53 | ||||||
cash-flows.row.purchases-of-investments | -5.65 | 0 | -3579.7 | -5.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 1.58 | 0 | 0.7 | 5.3 | ||||||
cash-flows.row.other-investing-activites | -577.8 | 0 | 43.5 | 4.4 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | -634.95 | 0 | -3585.6 | -50.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -5 | -6.5 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 4033.1 | ||||||
cash-flows.row.common-stock-repurchased | -0.68 | 0 | 5 | 0 | ||||||
cash-flows.row.dividends-paid | -124.69 | 0 | -12.1 | -92 | ||||||
cash-flows.row.other-financing-activites | -7.76 | 0 | -10.2 | -142.6 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -133.13 | 0 | -22.4 | 3792.1 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 63.06 | 0 | 329.9 | -53.9 | ||||||
cash-flows.row.net-change-in-cash | 1308.37 | 0 | -3200.9 | 3732 | ||||||
cash-flows.row.cash-at-end-of-period | 6009.58 | 678.2 | 678.2 | 3879.1 | ||||||
cash-flows.row.cash-at-beginning-of-period | 4701.21 | 678.2 | 3879.1 | 147.1 | ||||||
cash-flows.row.operating-cash-flow | 101.87 | 0 | 77.2 | 44.4 | ||||||
cash-flows.row.capital-expenditure | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.free-cash-flow | 101.12 | 0 | 69.7 | 42.5 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 412 | 412 | 314.1 | 284.4 | ||||||
income-statement-row.row.cost-of-revenue | 160.67 | 160.7 | 101.3 | 83.7 | ||||||
income-statement-row.row.gross-profit | 251.34 | 251.3 | 212.7 | 200.7 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 54.26 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 141.3 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.operating-expenses | 182.51 | 173.6 | 143.4 | 126.9 | ||||||
income-statement-row.row.cost-and-expenses | 343.18 | 334.2 | 244.7 | 210.7 | ||||||
income-statement-row.row.interest-income | 184.31 | 183.9 | 66.2 | 7.7 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.total-operating-expenses | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.depreciation-and-amortization | 3.91 | 9.4 | 9 | 6.1 | ||||||
income-statement-row.row.ebitda-caps | 69.05 | - | - | - | ||||||
income-statement-row.row.operating-income | 65.14 | 65 | 134.8 | 70.3 | ||||||
income-statement-row.row.income-before-tax | 253.13 | 253.1 | 135 | 69.9 | ||||||
income-statement-row.row.income-tax-expense | 1.37 | 1.4 | 8.6 | 24.7 | ||||||
income-statement-row.row.net-income | 242.3 | 242.3 | 117.3 | 40.6 |
Usein kysytty kysymys
Mikä on Medlive Technology Co., Ltd. (2192.HK) taseen loppusumma?
Medlive Technology Co., Ltd. (2192.HK) kokonaisvarat ovat 4893816000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on 238498000.000.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.610.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.138.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.588.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.158.
Mikä on Medlive Technology Co., Ltd. (2192.HK) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 242301000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 8192000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 173579000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 4358255000.000.